@article{2e90e90bfce044eba5955ba4638beee6,
title = "Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study",
abstract = "Atazanavir and lopinavir represent the main HIV protease inhibitors recommended in pregnancy, but comparative data in pregnant women are limited.",
keywords = "Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Female, HIV Infections, HIV RNA, Humans, Lipids, Liver Function Tests, Lopinavir, Oligopeptides, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pyridines, RNA, Viral, Viral Load, bilirubin, cholesterol, pre-term delivery, triglycerides, Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Female, HIV Infections, HIV RNA, Humans, Lipids, Liver Function Tests, Lopinavir, Oligopeptides, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pyridines, RNA, Viral, Viral Load, bilirubin, cholesterol, pre-term delivery, triglycerides",
author = "Enrica Tamburrini",
year = "2014",
doi = "10.1093/jac/dkt497",
language = "English",
volume = "69",
pages = "1377--1384",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL:
[email protected], INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485",
}
